AN2 Therapeutics enters $80 million share sale agreement with Jefferies Apr 9, 2026 05:07PM
AN2 Therapeutics to Participate at Upcoming Investor Conferences Feb 20, 2025 07:00AM
TD Cowen Downgrades AN2 Therapeutics (ANTX) to Hold Nov 18, 2024 02:43AM
AN2 Therapeutics Announces Pricing of $70.0 Million Underwritten Offering of Common Stock Aug 15, 2023 10:42PM
AN2 Therapeutics to Participate in Upcoming Investor Conferences Feb 28, 2023 04:10PM


Apr 19, 2022 05:33AM Cowen Starts AN2 Therapeutics (ANTX) at Outperform
Mar 25, 2022 12:20PM AN2 Therapeutics (ANTX) IPO Opens 13% Higher
Mar 25, 2022 05:50AM AN2 Therapeutics, Inc (ANTX) Prices Upsized 4.6M Share IPO at $15/sh
Mar 24, 2022 10:32PM AN2 Therapeutics Announces Pricing of Upsized Initial Public Offering
Mar 4, 2022 04:10PM UPDATE: AN2 Therapeutics, Inc (ANTX) Files IPO Registration Statement